Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Tenet Healthcare Corp Issues Q2 2013 EBITDA Guidance In Line With Analysts' Estimates; Reaffirms FY 2013 EBITDA Guidance


Tuesday, 30 Apr 2013 08:30am EDT 

Tenet Healthcare Corp announced that for second quarter of 2013, it expects adjusted EBITDA in the range of $325-$375 million. This second quarter Outlook includes expected contributions to EBITDA of $54 million related to the anticipated approval of the managed care portion of the 30-month California Provider Fee program and $31 million from the recognition of HIT incentives. The Company reaffirmed its previously announced guidance for fiscal 2013 adjusted EBITDA of $1.325 billion to $1.425 billion. According to I/B/E/S Estimates, analysts are expecting the Company to report EBITDA of $355 million for second quarter of 2013 and EBITDA of $1.35 billion for fiscal 2013.